Elanco Animal Health Stock
Elanco Animal Health Incorporated
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- United States
- CEO
- Jeffrey N. Simmons
- Employees
- 9,650
- Market cap
- $11.8 B
- IPO
- 20/09/2018
Elanco Animal Health Incorporated is a healthcare company operating in the Drug Manufacturers - Specialty & Generic industry. Headquartered in Indianapolis, USA, the firm was established in 1954 and employs approximately 9,650 people. The company creates, produces, and commercializes a diverse array of solutions for…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Elanco Animal Health stock: price history
1D
+0.0%
1W
+2.7%
1M
+3.0%
6M
-0.5%
YTD
+4.1%
1Y
+14.8%
2Y
+77.6%
5Y
-27.6%
10Y
–
Next earnings date
Next earnings date
06/11/2026 (in 20 days)
Volatility around earnings
~93% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vsqueeze-release-v1.0 on 15/10/26. Not a buy or sell signal.Beta
What does this mean?
Volatility squeeze
BullishPrice swings had compressed unusually tight beforehand (volatility near a low) and are now releasing into a stronger move. Technical analysis views such tight phases as often preceding a bigger move.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Elanco Animal Health stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Ask the agents about Elanco Animal Health
Analyst assessment of Elanco Animal Health
PRICE TARGET LOW
US$26.00
CONSENSUS
US$28.00
MEDIAN
US$28.00
PRICE TARGET HIGH
US$30.00
0
STRONG BUY
15
BUY
4
HOLD
2
SELL
0
STRONG SELL
21
TOTAL · Buy
As of: 06/08/2026
Elanco Animal Health stock metrics
P/E
-57.44
P/B
1.79
EV/EBITDA
19.57
RETURN ON EQUITY
0.8%
NET MARGIN
3.9%
DEBT/EQUITY
0.59
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
99.0%
FLOAT SHARES
494,547,339
AVG. DAILY VOLUME (30D)
5,312,239
Insider transactions (SEC)
Kurzius Lawrence Erik
O'Neill Shiv
Harrington Michael J
Herendeen Paul
VanHimbergen Robert M
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: +0.0%
Forums (Reddit)
Institutional holders
Smart Money
Register for free
Register now to see which funds are invested
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Comparable stocks
Frequently asked questions about Elanco Animal Health stock
What does Elanco Animal Health do?
Elanco Animal Health Incorporated is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in United States.
The CEO is Jeffrey N. Simmons, the company employs around 9,650 people.
The IPO was on 20/09/2018; the stock trades on NYSE under the ticker ELAN.
What do analysts say about Elanco Animal Health stock?
21 analysts rate the stock, the consensus is Buy (as of 06/08/2026).
The average price target is US$28.00, ranging from US$26.00 to US$30.00, with a median of US$28.00.
This is an external assessment, not a statement by Market Jury.
When does Elanco Animal Health report next?
The next earnings date is 06/11/2026.
Around past earnings, price swings were roughly 93% stronger than usual.
Does Elanco Animal Health pay a dividend?
No, Elanco Animal Health currently does not pay a dividend.
Which stocks are comparable to Elanco Animal Health?
Comparable stocks include Zoetis, Viatris, Lantheus Holdings, Amneal Pharmaceuticals, Indivior Pharmaceuticals, Eton Pharmaceuticals, Pacira BioSciences and Amphastar Pharmaceuticals.
How can I get Elanco Animal Health stock analyzed?
Clicking "Analyze stock" lets five strategies assess Elanco Animal Health against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.